Target intelligence / Profile preview

Methyl-accepting chemotaxis protein 4 (MCP-4)

Target
MCP-4
Molecular classification
Receptor, Transmembrane protein, Chemoreceptor, Bacterial sensory transducer
01

Overview

Methyl-accepting chemotaxis protein 4 (MCP-4) is a specialized transmembrane receptor found in bacteria, including Escherichia coli (where it is known as Tap) and Borrelia burgdorferi (BB0680). It functions as a sensory transducer that detects environmental chemical signals—such as dipeptides in E. coli—and relays this information to the flagellar motor to direct bacterial movement, a process essential for nutrient acquisition and host colonization [1, 2, 28]. In pathogenic species like Borrelia burgdorferi, the causative agent of Lyme disease, MCP-4 has been identified as a major immunogenic protein that triggers CD4+ T cell responses and contributes to the inflammatory pathology of the disease [7, 14, 20]. While no therapeutic drugs currently target MCP-4, it is an active area of research for the development of anti-virulence therapies and vaccines aimed at preventing bacterial infections by disrupting their ability to navigate and persist within the host [2, 3, 31]. Its role as a specific bacterial antigen also makes it a potential candidate for diagnostic biomarkers in infectious diseases [14, 19].

Other names
TapMethyl-accepting chemotaxis protein IVBB0680Peptide sensor receptorMcp4
02

Mechanism of action

Inhibition of bacterial chemotaxis and host colonization

03

Biological functions

Signal transductionChemotaxisSensory perceptionBacterial motilityImmune response
04

Disease associations

InfectionLyme diseaseCampylobacteriosisInflammation
05

Safety considerations

Potential disruption of commensal microbiotaSpecies-specific targeting challenges
06

Biomarkers

Anti-Mcp4 antibodies (Lyme disease diagnosis)

Beyond the preview

Go deeper on Methyl-accepting chemotaxis protein 4 (MCP-4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Methyl-accepting chemotaxis protein 4 (MCP-4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call